Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy (Scientific Reports, (2020), 10, 1, (17237), 10.1038/s41598-020-74174-x)

Yasuhisa Sando, Ken ichi Matsuoka, Yuichi Sumii, Takumi Kondo, Shuntaro Ikegawa, Hiroyuki Sugiura, Makoto Nakamura, Miki Iwamoto, Yusuke Meguri, Noboru Asada, Daisuke Ennishi, Hisakazu Nishimori, Keiko Fujii, Nobuharu Fujii, Atae Utsunomiya, Takashi Oka, Yoshinobu Maeda

Research output: Contribution to journalComment/debatepeer-review

Abstract

The Supplementary Information published with this Article contains errors. The degree of Takashi Oka, “PhD., DMSc”, is incorrectly given as “PhD”. In addition, the excitation wavelength measurements within the “Supplemental materials and methods” section is omitted. Lastly, the explanation of the Figures given in the legend of Figures S4 and S5 is incorrect. The correct Supplementary Information file is linked to this correction notice.

Original languageEnglish
Article number6420
JournalScientific reports
Volume11
Issue number1
DOIs
Publication statusPublished - Dec 2021

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy (Scientific Reports, (2020), 10, 1, (17237), 10.1038/s41598-020-74174-x)'. Together they form a unique fingerprint.

Cite this